Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02753933
Other study ID # MRI headache v2.0
Secondary ID
Status Recruiting
Phase N/A
First received April 25, 2016
Last updated August 7, 2017
Start date April 2016
Est. completion date December 2018

Study information

Verified date August 2017
Source Guy's and St Thomas' NHS Foundation Trust
Contact Yvonne Akande, Master
Email yvonne.akande@kcl.ac.uk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to evaluate whether direct access from General Practitioners (GPs) to Magnetic Resonance Imaging (MRI) for patients with chronic headache decreases overall NHS costs and increases patient satisfaction compared to clinical practice with referral to Neurology Services.


Description:

Headache is the most common symptom reported in the community, affecting more than 90% of the population at some point in their lifetime. Despite the low level of referrals to secondary care (as most patients tend to be managed within primary care), the absolute number of headache episodes (due to its high prevalence) makes headache the most frequently listed reason for referral to the Neurologist and thus, utilises precious capacity that is severely constrained.

In order to support future management of this chronic condition, this study aims to evaluate existing clinical pathways in the management of patients with chronic headache - either referral to the Neurology Department or direct access to Imaging. Participants will be followed-up for a period of 12 months after the initial Secondary Care episode (either an MRI scan or Neurology appointment). Costs from the NHS perspective and self-perceived patient quality of life will be assessed and cost per patient and cost-effectiveness analyses will be performed.


Recruitment information / eligibility

Status Recruiting
Enrollment 296
Est. completion date December 2018
Est. primary completion date June 2018
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria:

- Every patient aged 16 years or over with: i) chronic headache as a primary cause that has lasted = 15 days per month for more than 3 months; and ii) referred from GP practices to GSTT, either directly referred to an MRI exam or a Neurology outpatient appointment.

Exclusion Criteria:

- Children under the age of 16;

- Patients with red flags as defined in NICE guideline CG150;

- Patients without chronic primary headache, i.e. a headache that has not persisted for = 15 days per month for more than 3 months

- Patients with headache referred through the two week wait list;

- Patients who lack capacity to give consent or participate in the study;

- Patients not fluent in English;

- Prisoners;

- Patients that are already taking part in a clinical trial of an investigational medicinal products (CTIMPs).

Study Design


Related Conditions & MeSH terms


Intervention

Other:
MRI scan
MRI head scan to be performed as the first Secondary Care contact.
Neurology Appointment
Outpatient appointment with Neurologist as the first Secondary Care contact

Locations

Country Name City State
United Kingdom Guy's and St Thomas' NHS Foundation Trust London

Sponsors (2)

Lead Sponsor Collaborator
Guy's and St Thomas' NHS Foundation Trust King's College London

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary 6-month cost analysis per patient referred to either MRI or Neurology (measured in £ per patient) The primary objective is to evaluate whether direct access from General Practitioners (GPs) to Magnetic Resonance Imaging (MRI) for patients with chronic headache is associated with cost-savings at 6 months after the initial episode at Secondary Care (either an MRI scan or a Neurology Outpatient appointment) compared to clinical practice with referral to the Neurology Department. 6 months after the initial episode at Secondary Care (either an MRI scan or Neurology Outpatient appointment)
Secondary 12-month cost analysis per patient referred to either MRI or Neurology (measured in £ per patient) This secondary objective is aimed at evaluating whether direct access from General Practitioners (GPs) to Magnetic Resonance Imaging (MRI) for patients with chronic headache is associated with cost-savings at 12 months after the initial episode at Secondary Care (either an MRI scan or a Neurology Outpatient appointment) compared to clinical practice with referral to the Neurology Department. 12 months after the initial episode at Secondary Care (either an MRI scan or Neurology Outpatient appointment)
Secondary 6-month cost-effectiveness analysis per patient referred to either MRI or Neurology (measured in £ per QALY) This secondary objective is aimed at evaluating whether direct access from General Practitioners (GPs) to Magnetic Resonance Imaging (MRI) for patients with chronic headache is cost-effective at 6 months after the initial episode at Secondary Care (either an MRI scan or a Neurology Outpatient appointment) compared to clinical practice with referral to the Neurology Department. 6 months after the initial episode at Secondary Care (either an MRI scan or Neurology Outpatient appointment)
Secondary 12-month cost-effectiveness analysis per patient referred to either MRI or Neurology (measured in £ per QALY) This secondary objective is aimed at evaluating whether direct access from General Practitioners (GPs) to Magnetic Resonance Imaging (MRI) for patients with chronic headache is cost-effective at 12 months after the initial episode at Secondary Care (either an MRI scan or a Neurology Outpatient appointment) compared to clinical practice with referral to the Neurology Department. 12 months after the initial episode at Secondary Care (either an MRI scan or Neurology Outpatient appointment)
Secondary Patient satisfaction associated with both clinical pathways (direct referral to MRI or Neurology) To evaluate and compare the levels of patient satisfaction associated with the two pathways: i) with direct access to MRI from Primary Care; and ii) with referral to the Neurology Department. A patient satisfaction questionnaire will be used to quantify patient satisfaction at 6 months. 6 months
Secondary Patient's self perceived quality of life - measured using EQ-5D-5L questionnaire This objective aims to evaluate the patient's self-perceived quality of life associated with both pathways using a standard questionnaire (EQ-5D-5L). 6 months
Secondary Patient's self perceived quality of life - measured using HIT-6 questionnaire This objective aims to evaluate the patient's self-perceived quality of life associated with both pathways using a standard headache-specific questionnaire (HIT-6 questionnaire). 6 months
Secondary Patient's self perceived quality of life - measured using MIDAS questionnaire This objective aims to evaluate the patient's self-perceived quality of life associated with both pathways using a standard headache-specific questionnaire (MIDAS questionnaire). 6 months
Secondary Time-off work (measured in half days) due to chronic headache To evaluate the headache burden and time-off work (both measured in half days) due to the chronic headache associated with the pathway with direct access to MRI compared with referral to the Neurology Department. 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05414513 - The Turkish Fear of Pain Questionnaire
Not yet recruiting NCT06077747 - Lumbar Vein Embolization for Chronic Headaches With Nutcracker Physiology N/A
Completed NCT02514148 - Biobehavioral Physical Therapy Strategies Based on Therapeutic Exercise Applied to Chronic Migraine Patients N/A
Not yet recruiting NCT00897780 - Combined Biofeedback With Virtual Reality in the Treatment of Pediatric Headache N/A
Completed NCT00228267 - Propofol Injection for Daily Headache Phase 2
Completed NCT02684916 - Chiropractic Treatment for Headache Among Children Aged 7-14 N/A
Not yet recruiting NCT05613582 - The Effectiveness of Transcranial Direct Current Stimulation as Adjunctive Treatment for Chronic Daily Headache in Systemic Lupus Erythematosus N/A
Completed NCT02440997 - A Preliminary Investigation of the Efficacy of Aromatherapy in Reducing Discomfort in Youth With Chronic Headache N/A
Completed NCT01314768 - Brief Intervention for Medication Overuse Headache N/A
Enrolling by invitation NCT06127888 - Impementation of the Exercise Recommendations for the Treatment of Primary Headaches: A Qualitative Approach to the Headache Units in Catalonia
Completed NCT00417742 - Project CHEER (Comprehensive Headache Evaluation, Education, Relief) N/A
Terminated NCT02141568 - Effectiveness of Mind-Body Interventions for Frequent Attendees Suffering From Medically Unexplained Symptoms (MUS) N/A
Recruiting NCT04195685 - Neurofeedback Impact on Veterans With mTBI N/A
Completed NCT03080779 - Long Term Outcomes After Accidental Dural Puncture ADP Study
Not yet recruiting NCT00286923 - Does Topiramate Adjust the Excitability of the Brain in Migraine Sufferers? N/A
Completed NCT04696627 - Long-term Complications of Unintentional Dural Puncture During Labour Epidurals and Epidural Blood Patch.
Recruiting NCT02302027 - Feasibility Study of Normobaric Oxygen Delivered by a High Flow Concentrator in the Treatment of Chronic Headache N/A
Completed NCT03503734 - Integrated Care for Migraine and Chronic Tension-type Headaches